Digital Marketing & Social Media in Pharma Reviewed in New Study Published at MarketPublishers.com

23 Jan 2012 • by Natalie Aster

LONDON – Today, digital channels offer life science companies enormous untapped opportunities to reach and interwork with physicians and patients. Some marketing teams have already responded by boosting their digital activity, with growth trends indicating that some digital channels will surpass more traditional media tools.

However, a host of challenges faced by the industry like regulatory compliance, ROI, adverse events monitoring, etc. leave companies behind the curve as they try to navigate both opportunities and hidden dangers. Meanwhile, leading-edge firms forge ahead by integrating digital tools into overall brand - and corporate-level strategies.

New research study “Pharmaceutical Digital Marketing and Social Media” worked out by Cutting Edge Information has been recently published by Market Publishers Ltd.

Report Details:

Pharmaceutical Digital Marketing and Social Media
Published: December, 2011
Pages: 187
Price: US$ 7.695,00

The report is a must-have for those who want to:

• explore real-world marketing mixes, case studies and rankings to understand industry-wide usage and goals for digital marketing, social media and mobile technology;
• learn how leading companies manage compliance, gauge ROI and avoid outsourcing pitfalls; as well as explore how digital models help teams mitigate regulatory risks and earn internal buy-in for new initiatives.;
• benchmark structure, staffing, budget and reporting lines to develop a team equipped to face challenges both now and in the future.

More new studies by the publisher can be found at Cutting Edge Information page.

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com